Cited by 1,163COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRenin-Angiotensin System Studies

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

Open access

Chen, Liang, Li, Xiangjie, Chen, Mingquan, Feng, Yi, Xiong, Chenglong·2020·Cardiovascular Research

Open this paper in CoChat — free account Open PDF

Abstract

A new type of pneumonia caused by a novel coronavirus SARS-CoV-2 outbreaks recently in China and spreads into many other countries. This disease, named as COVID-19, is similar to patients infected by SARS-CoV and MERS-CoV, and nearly 20% of patients developed severe condition. Cardiac injury is a prevalent complication of severe patients, exacerbating the disease severity in coronavirus disease 2019 (COVID-19) patients. Angiotensin-converting enzyme 2 (ACE2), the key host cellular receptor of SARS-CoV-2, has been identified in multiple organs, but its cellular distribution in human heart is not illuminated clearly. This study performed the first state-of-art single cell atlas of adult human heart, and revealed that pericytes with high expression of ACE2 might act as the target cardiac cell of SARS-CoV-2. The pericytes injury due to virus infection may result in capillary endothelial cells dysfunction, inducing microvascular dysfunction. And patients with basic heart failure disease showed increased ACE2 expression at both mRNA and protein levels, meaning that if infected by the virus these patients may have higher risk of heart attack and critically ill condition. The finding of this study explains the high rate of severe cases among COVID-19 patients with basic cardiovascular disease; and these results also perhaps provide important reference to clinical treatment of cardiac injury among severe patients infected by SARS-CoV-2.

Integrity signals

Registry

Crossref · 10.1093/cvr/cvaa078

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · cited 5×
“Clinical characteristics of coronavirus disease 2019 in China.”
BackgroundMethodInfluential
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066 · cited 1×
“Cardiac injury was observed among 23% of severe patients.(3) Even in the general COVID-19 patient cohort, the creatinine kinase (CK) elevation (>200 U/L) was observed in 13%”
Background
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,116 · cited 1×
“Digestive tract intestine displayed the highest expression of ACE2, followed by testis and kidney, suggesting the vulnerability to virus in these organs, which could explain the positive detection of SARS-CoV-2 in patients’ faeces and urine.(6) The expression of ACE2 in the heart is lower than that in the intestine an…”
Background
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 611
The Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease
Bilimoria, J., & Singh, H. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1652650 · Cited by 37 · cited 1×
“As the molecular balance between ANGPT1:ANGPT2 and TIE2:TIE1 is important in determining endothelial stability, 7 it is suggested that pericytes play an important role in maintaining EC function in capillary vessels.”
Background
Comprehensive Myocardial Proteogenomics Profiling Reveals C/EBPα as the Key Factor in the Lipid Storage of ARVC
Chen, L., Yang, F., Chen, X., Rao, M., Zhang, N., Chen, K., Deng, H., Song, J., & Hu, S. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00165 · Cited by 33
Self-citation

Flagged first, then by citations

Show all 7 references

Sorted by citations

Items 901–999 of 999

Cardiovascular imaging in COVID-19: insights into features and complications
Duraj, I., Kilarska, M., Pawlos, A., & Wierzbowska-Drabik, K. A. (2023) · Exploration of Cardiology · doi:10.37349/ec.2023.00008 · Cited by 1
Sympathetic remodeling and altered angiotensin-converting enzyme 2 localization occur in patients with cardiac disease but are not exacerbated by severe COVID-19
Kellum, C. L., Kirkland, L. G., Nelson, T. K., Jewett, S. M., Rytkin, E., Efimov, I. R., Hoover, D. B., Benson, P. V., & Wagener, B. M. (2023) · Autonomic Neuroscience · doi:10.1016/j.autneu.2023.103134 · Cited by 1
Association of New-Onset Atrial Fibrillation With All-Cause Mortality in COVID-19 Patients
Zaheer, K., Gonçalves, B. D. S., Ramalingam, A., Rabbani, N. U. A., Sayyed, R., Nawab, A., Puri, R., Williams, C. J., & Mansoor, K. (2023) · Cureus · doi:10.7759/cureus.49785 · Cited by 1
“…of the pericardium, instigating significant edema [15]; (3) ischemia from microvascular disease due to possible infection of the pericytes [16,17]; (4) the induction of re-entrant arrhythmias attributable to myocardial fibrosis [18]; (5) the influence of proinflammatory cytokines,…”
Background
Patological changes in cardiovascular system among the patients with post-COVID-19 syndrome
Akimochkin, G. S., Volgograd, R. F., Matokhin, S. E., Skvortsov, V. V., Skvortsova, E. M., & Saraev, S. S. (2023) · Therapist’s Bulletin · doi:10.31550/2712-8601-vt-2023-5-6-2 · Cited by 1
A study of clinical and serological correlation of early myocardial injury in elderly patients infected with the Omicron variant
Yu, X., Li, X., Xia, S., Lu, L., Fan, J., Wang, Y., Fu, Y., Suo, C., Man, Q., & Xiong, L. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1268499 · Cited by 1
“SARS-CoV-2 can directly invade cardiomyocytes by binding to ACE2 receptors on the surface of cardiomyocytes (21 – 23).”
BackgroundSelf-citation
Proteomic characteristics of the treatment trajectory of patients with COVID-19
Li, X., Ding, G., Li, S., Liu, C., Zheng, X., Luo, J., He, S., Zeng, F., Huang, X., & Zeng, F. (2024) · Archives of Virology · doi:10.1007/s00705-024-05991-y · Cited by 1
“SARS-CoV-2 infects host cells through ACE2 and can cause damage to the myocardium [35, 36], although the specific mechanisms are uncertain.”
Self-citation
Unraveling the Complex Interplay: COVID-19 and Heart Failure: A Comprehensive Review
Deiveegan, D. S., Singh, A., Shazi, M. I., Rehman, W. U., Akram, M. R., Tauqeer, S., Raval, D. M., Bibi, R., Subhan, M., & Manoharasetty, A. (2024) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2024/v36i65461 · Cited by 1
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function
Padín, J. F., Pérez‐Ortiz, J. M., & Calvo, F. J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147553 · Cited by 2
“This inappropriate response is also aggravated by infection of vascular basement membrane pericytes [245,246], which have high ACE2 expression [245,247].”
Background
Human Pluripotent Stem Cell–Derived Cardiomyocytes for COVID-19 Cardiovascular Complications: A Versatile In Vitro Model for Studying Acute and Chronic SARS-CoV-2 Infection
Lopez-Munoz, C., Bowers, N. J., & Marchianò, S. (2025) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-025-01079-1 · Cited by 1
“Importantly, despite absence of direct infection in non-cardiac cells, exposure to the virus significantly modified their transcriptome, suggesting that, besides CMs, SARS-CoV-2 could induce phenotypic changes in other cells of the heart, even in the absence of direct infection [31, 90, 92].”
Complications associated with covid-19: A comprehensive review
Naeem, M. (2025) · Journal of Contemporary Pharmacy · doi:10.56770/jcp20259110 · Cited by 1
A renin–angiotenzin–aldoszteron rendszer gátlása súlyos akut légúti tünetegyüttest okozó koronavírus 2 (SARS-CoV-2) járvány idején
Nagy, V. (2020) · Cardiologia Hungarica · doi:10.26430/chungarica.2020.50.2.93 · Cited by 1
Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System
Pucci, F., Bogaerts, P., & Rooman, M. J. (2020) · Viruses · doi:10.3390/v12121367 · Cited by 2
Complicated AMI in a COVID-19 Patient; Chordal Rupture and Flail of Mitral Valve
Alizadehasl, A., Salehi, P., Roudbari, S., Fesharaki, M. J., Moradian, M., Firouzi, A., & Mostafavi, A. (2020) · Multidisciplinary Cardiovascular Annals · doi:10.5812/mca.106953 · Cited by 1
“non-invasive management of patients presenting with ACS and COVID-19 should be carefully considered (1, 2, 10-12).”
Background
Treatment of Multi-Drug Resistant Gram-Negative Bacterial Pathogenic Infections
Akram, W. M., Menezes, G. A., Abbas, N., Ahmad, W., & Ahmed, A. M. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.3.02 · Cited by 1
Myocardial Injury and Myocarditis in SARS-CoV-2 Patients
Libenciuc, C., Licu, R.-A., Hodaş, R., Chițu, M., & Benedek, I. (2020) · Journal of Interdisciplinary Medicine · doi:10.2478/jim-2020-0019 · Cited by 1
Coronaviruses and the cardiovascular system
(2018) · Oxford University Press eBooks · doi:10.1093/med/9780198784906.003.0800 · Cited by 1
Histopathological and Serological Findings of Lung, Liver and Heart in a Patient with Corona Virus Disease-2019 (COVID -19): A Case Report
Naseri, E., Mohammadghasemi, F., Shams, F., Saliminasab, S., Karimian, P., Taramsari, M. R., Kordrostami, S., Foumani, A. A., Hemmati, H., Hojati, A., et al. (2021) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambs.29.134.183 · Cited by 1
“In 23% of the patients, COVID-19 was associated with the cardiac injury (5).”
Background
Stroke in critical COVID-19 patients: a cautionary tale from the frontlines
Jain, A., Jafri, F. M., Manglani, R., Al‐Mufti, F., Aronow, W. S., & Chandy, D. (2020) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2020.102423 · Cited by 1
“Endothelial cell dysfunction – The virus may initially invade endothelial cells through ACE2 receptors [12].”
Background
Impact of COVID-19 on Cardiovascular Patients and Review of Current COVID-19 Treatment Strategies
Alfawaz, D. A., Alfawaz, M. A., & Almutawa, A. M. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2020/v32i4231056 · Cited by 1
“express the highest levels of ACE2 [7, 8], endothelial and cell cardiomyocytes also express ACE2 [9].”
Background
COVID- 19 and Cardiovascular Diseases: The Vicious Cycle
Sen, R. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.30.004881 · Cited by 1
“A recent study involving state-of-art cardiac single cell atlas of adult humans demonstrated a link between COVID-19 and the elevated expression of ACE2 in pericytes, which are cells of the basement membrane that encompass the endothelial cells of capillaries and venules [14].”
Background
Angiotensin-Converting-Enzyme 2 and SARS-CoV2: A Dangerous Liaison
Sturza, A., Marian, C. V., Muntean, D. M., & Cretu, O. M. (2020) · Timişoara Medical Journal · doi:10.35995/tmj20200108 · Cited by 1
“An elevated activity and ACE2 gene expression in pericytes (as compensatory mechanisms) were reported in patients with heart failure and were correlated with severity of the disease [29].”
Background
Cardiac Complications in Patients Infected with COVID-19
Leon, M. M., Maștaleru, A., Abdulan, I. M., Zota, M. I., Cojocariu, S. A., & Mitu, F. (2020) · Internal Medicine · doi:10.2478/inmed-2020-0134 · Cited by 1
A Therapeutic Journey of Potential Drugs Against COVID-19
Ali, F., Zhu, Y. Z., & Hussain, S. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210412161157 · Cited by 1
Cardiovascular Burden of COVID-19 and the Post-Covid Era
Moscavitch, S. D., Vieira, J. L., & Libby, P. (2021) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20210001 · Cited by 1
Transcriptomic Approaches in Understanding SARS-CoV-2 Infection
Charles, S., & Natarajan, J. (2021) · Springer eBooks · doi:10.1007/978-981-16-0691-5_13 · Cited by 1
Coronary arteries and aortic valve calcifications in COVID-19: Not only lungs at chest CT
Azienda Ospedaliero-Universitaria “Ospedali Riuniti” Ancona, I., Fogante, M., Cavagna, E., Ospedale “Infermi” Rimini, I., Rinaldi, G., & Ospedale “Infermi” Rimini, I. (2021) · Journal of Clinical Images and Medical Case Reports · doi:10.52768/2766-7820/1355 · Cited by 1
“COVID-19 might cause injuries to the cardiovascular system with different mechanisms: the SARS-CoV-2 host cell receptors, the angiotensin-converting enzyme 2, are expressed in the myocardial and endothelial cells; this could possibly be a reason for a direct damage; moreover, the excessive production of proinflammator…”
REMOVED: Correlation between COVID-19 and cardiac calcification
Fogante, M., Cavagna, E., & Rinaldi, G. (2022) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2022.01.002 · Cited by 1
Retracted
Past COVID-19 infection and feasibility of transcatheter aortic valve replacement in a patient with severe aortic stenosis (a clinical case study)
Zemlyanskaya, O. A., Kurilina, E. V., & Панченко, Е. П. (2022) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2021-11-2-122-134 · Cited by 1
“Помимо легких, ACE2 экспрессируется в пищеварительном тракте, почках, яичках, а также миокарде, сосудистых клетках и перицитах человека [21, 22].”
The Renin-Angiotensin System in COVID19
Mallick, U. (2022) · Springer eBooks · doi:10.1007/978-3-030-90065-6_8 · Cited by 1
Acute Coronary Syndromes in CoViD19
Mallick, U. (2022) · Springer eBooks · doi:10.1007/978-3-030-90065-6_15 · Cited by 1
Relación entre el sistema renina angiotensina aldosterona y las complicaciones cardiovasculares por SARS-CoV-2
López, A. A. P., Aubry, V. P., Jalil, H. A. L., Carmona, I. C., & Juarez, V. (2022) · Anales Médicos de la Asociación Médica del Centro Médico ABC · doi:10.35366/104366 · Cited by 1
Cardiovascular System and SARS-CoV-2: Etiology, Physiopathology and Clinical Presentation: A Systematic Review
Júnior, J. G., Cândido, E. L., de Oliveira, G. F., & Neto, M. L. R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97076 · Cited by 1
Brief Pathophysiology
Bona, R. D., Canale, C., & Benenati, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-94992-1_12 · Cited by 1
Multifactorial Effects of COVID-19: A Review of Published Autopsy Reports
Chawla, K., Hong, S., Shields, R., Ford, A., Pacella, G., & Lurie, F. (2022) · COVID · doi:10.3390/covid2050041 · Cited by 1
The Importance of Cardiometabolic Risk Factors During the COVID-19 Pandemic: Review of the Сonsensus Paper from the European Society of Cardiology
Суджаева, О. А. (2022) · Рецепт · doi:10.34883/pi.2022.25.4.006 · Cited by 1
Pros and Cons for COVID-19 Vaccination and Boost of Young Adults in Light of Recent Literature
Nemunaitis, J. J., Lehmann, P., & Willey, J. C. (2022) · Medical Research Archives · doi:10.18103/mra.v10i8.2943 · Cited by 1
Management of patients with hypertension, coronary heart disease and chronic heart failure during the COVID-19 pandemic in the primary care setting
Конради, А. О., Drapkina, O. M., Nedogoda, S. V., Arutyunov, G. P., IuA, K., Кобалава, Ж. Д., Orlova, Y. A., Sychev, D. A., & Zyryanov, S. K. (2022) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2022-28-4-464-476 · Cited by 1
COVID-19 x cardiovascular system: clinical evolution, risk factors and myocardial injury mechanism
Dorigo, B. C., Lins, M. M. D., Silva, F. D., Passos, H. A. S., Araújo, B. C. D., Guatimosim, B. G., Santos, M. L. G. D., & Borges, V. F. A. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n4-213 · Cited by 1
The epidemiology, evolution, transmission, and therapeutics of COVID-19 Outbreak: an update on the statusPreprint
Labana, K. S., Mittal, A. K., & Gujral, A. (2020) · Preprints.org · doi:10.20944/preprints202004.0525.v1 · Cited by 1
Cardiovascular complications of COVID-19: evidence, misconceptions, and new opportunities
Madeddu, P. R. (2020) · Vascular Biology · doi:10.1530/vb-20-0008 · Cited by 1
Renin-Angiotensin-Aldosterone-System Blocking Drugs in Patients with SARS-CoV-2 - Systematic Review and Meta-AnalysisPreprint
Chu, C., Zeng, S., Hasan, A., Hocher, C., Kraemer, B., & Hocher, B. (2020) · doi:10.22541/au.159170759.99707886 · Cited by 1
“…- likewise a primary target of SARS-CoV-2 infections leading to clinical signs of myocarditis and heart failure (Chen, Li, Chen, Feng & Xiong, 2020; Chen et al., 2020; Han et al., 2020; Madjid, Safavi-Naeini, Solomon & Vardeny, 2020) and potentially renal failure (Goicoechea et al., 2020; Noris,…”
Background
COVID cardiomyopathy
Chowdhury, M., Maharaj, V., Francis, G. S., Alexy, T., & Fraser, M. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_3760_20 · Cited by 1
The COVID-19 pandemic: A Comprehensive Review of the Genomic variations, Epidemiological features, Diagnosis, Treatment and Intervention schemes in South AsiaPreprint
Noman, A. A., Ekra, J. E., Meem, R. I., Islam, M. S., Sharzana, F., Islam, M. S., Sana, S., Mahmud, N., Kabir, M. M. M., Mahedi, A. A., et al. (2021) · doi:10.22541/au.160977415.51030001/v1 · Cited by 1
A Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO.IL-2Rγc KO. NOD) for COVID-19Preprint
Brumeanu, T., Vir, P., Karim, A. F., Kar, S., Benetiene, D., Lok, M., Greenhouse, J. J., Putman-Taylor, T., Kitajewski, C., Chung, K. K., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-225156/v1 · Cited by 1
Taxonomical and functional changes in COVID-19 faecal microbiome are related to SARS-CoV-2 faecal loadPreprint
Armengaud, J., Grenga, L., Pible, O., Miotello, G., Culotta, K., Ruat, S., Roncato, M., Gas, F., Bellanger, L., Claret, P., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-414136/v1 · Cited by 1
Lack of Benefit in COVID-19 Patients Treated with Hydroxychloroquine or Chloroquine: A Systematic Review and Meta-AnalysisPreprint
Chen, L., An, S., Yao, G., Xiong, J., Xiong, H., Zhao, P., Jiang, L., Hua, W., Xiong, C., Duru, F., et al. (2020) · doi:10.21203/rs.3.rs-33047/v2 · Cited by 1
Self-citation
County-Level Longitudinal Clustering of COVID-19 Mortality to Incidence Ratio in the United StatesPreprint
Vahabi, N., ‎Salehi, M., Duarte, J., Mollalo, A., & Michailidis, G. C. (2020) · doi:10.21203/rs.3.rs-40632/v1 · Cited by 1
ACE2: THE DOORWAY TO SARS-CoV-2Preprint
Medina-Enríquez, M. M., Carlos-Escalante, J. A., Torres, Z. A., Cuapio, A., López‐León, S., & Wegman-Ostrosky, T. (2020) · doi:10.31226/osf.io/bhpx8 · Cited by 1
Natural Causes of Sudden Death
Turillazzi, E., Santurro, A., Ricci, P., Scopetti, M., & Fineschi, V. (2022) · Wiley eBooks · doi:10.1002/9781119648628.ch34 · Cited by 1
COVID-19 mRNA Vaccines: From Inflammation to HyperinflammationPreprint
Giannotta, G., Murrone, A., & Giannotta, N. (2023) · Preprints.org · doi:10.20944/preprints202301.0460.v1
Yaqob Taleb. An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID-19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesPreprint
AlTaweel, M., Almusaad, A., Alkhazmari, G., Alrowaily, H., AlSubaiee, M., Husain, M. A., Alomayrin, N., Muaiweed, R. A., Aleid, N., Alarfaj, A. A., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4598063 · Cited by 1
Link Between the G Protein-Coupled Receptor (GPCR), SARS-CoV-2 Spike Protein, ACE2, Vaccines, and Long COVIDPreprint
Altable, M. (2024) · Preprints.org · doi:10.20944/preprints202403.0572.v1
Cardiovascular Complications Associated with COVID-19 Infection
Naji, H. S. (2020) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2020.2.4.343
“This provides an intrinsic susceptibility of heart to COVID-19 infection [1].”
Background
КОРОНАВІРУСНА ХВОРОБА (COVID-19): ОСОБЛИВОСТІ ПЕРЕБІГУ ТА ЛІКУВАННЯ ІНФАРКТА МІОКАРДА І СЕРЦЕВОІ НЕДОСТАТНОСТІ
Середюк, Н. М., Seredyuk, V., Skakun, O., Vandzhura, Y., & Твердохліб, І. З. (2020) · Art of Medicine · doi:10.21802/artm.2020.3.15.182
Autopsies Findings and Evolution of the Therapeutic Strategies of the SARS-CoV-2
Piacevoli, Q., Marchioni, L., & Garotto, G. (2020) · Acta Scientific Medical Sciences · doi:10.31080/asms.2020.04.0784
Angiotensin Converting Enzyme 2 in COVID-19 infections and the implications of COVID-19 on major body systems
Antoine, M. M. L. K., Xu, Y., Seyni-Boureima, R., Antoine-Frank, C. D., Thiam, C. A., & Ehya, R. E. M. (2020) · Journal of Advances in Internal Medicine · doi:10.3126/jaim.v9i2.32604
Coronavirus disease 2019–what do we know so far?
Pai, A., Hutchison, E., Urovi, S., Maccaroni, M. R., Namjoshi, G., Nain, N., & Serumadar, S. (2020) · The Egyptian Journal of Cardiothoracic Anesthesia · doi:10.4103/ejca.ejca_11_20
Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review
Khodashahi, R., Naderi, H., Bojdy, A., & Khodashahi, M. (2020) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x16999201202121247
Characterization of Confirmed and Suspected COVID-19 Pneumonia Patients in a Retrospective Cohort Study in WuhanPreprint
Xi, M., Cui, D., Liu, Q., Li, L., Yin, Y., Dong, F., Xiong, D., Wu, Y., Guo, H., Bao, M., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-92239/v1
Tracheal tube obstruction due to hemoptysis associated with pulmonary infarction in a patient with severe COVID-19 pneumonia: A case report.Preprint
Maruhashi, T., Kurihara, Y., Wada, T., Osada, M., Oi, M., Masuda, T., Yamaoka, K., & Asari, Y. (2020) · doi:10.21203/rs.3.rs-75925/v1
Endothel, vaskuläre Funktion und COVID-19
Kopp, S., Münzel, T. F., & Wenzel, P. (2020) · Aktuelle Kardiologie · doi:10.1055/a-1319-0964
SARS-Cov-2 Infection and Cardiology: Beware of Myocarditis
Machado, S. M. A., Breis, L. C., Bandeira, I. P., Ronsoni Rafael, M., Clizenaldo, T., & Magno, G. M. V. (2020) · International Journal of Tropical Diseases · doi:10.23937/2643-461x/1710031 · Cited by 2
Efectos de Bloqueadores del Receptor de Angiotensina II e inhibidores de la Enzima Convertidora de Angiotensina en COVID-19: Una revisión narrativa de la literatura
Loaiza, J. D. M., Infante-Fernández, H. S., Mahecha, B. S. P., Herrera-Cardona, J. E., & Jiménez, D. R. S. (2020) · Revista Investigación en Salud Universidad de Boyacá · doi:10.24267/23897325.473
Proxies for COVID-19 Diagnosis for Adults in Resource Limited Settings: A Case Series Study in Zambia.Preprint
Mutengo, K. H., Kachimba, J. S., & Mupeta, F. (2021) · Research Square · doi:10.21203/rs.3.rs-150178/v1
“This partially explains some clinical presentations like thrombosis initially thought to be an enigma, and a possible predilection of COVID-19 in diseases with ECD such as advanced age, cardiac diseases, hypertension, diabetes and obesity (6).”
Background
Association Between Covid-19 and Heart Failure: Evidence From a Two-sample Mendelian Randomization StudyPreprint
Wang, H., Guo, Z., Zheng, Y., & Chen, B. (2021) · Research Square · doi:10.21203/rs.3.rs-277791/v1
Report of the British Society for Cardiovascular Research Inaugural Online Autumn Meeting 2020
Arthur, H. M. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07161-7
“This finding is in line with findings from scRNAseq analysis of human heart tissue showing that ACE2 is primarily expressed in pericytes, with some cardiomyocyte expression, but is not detected in immune cells [6].”
Result
COVID-19 as Viewed by The Pathologist: A Rapid Literature Review
Callea, F. (2020) · Medical and Clinical Research Open Access · doi:10.52106/2766-3213.1010
“The pericyte injury due to virus infection may result in capillary endothelial cell dysfunction, inducing microvascular dysfunction [32].”
Background
The authors respond: Cardiac troponin levels in Covid-19 patients
Çınar, T., Hayıroğlu, M. İ., Çiçek, V., Kılıç, Ş., Asal, S., Doğan, S., ŞEKER, M. M., Selçuk, M., Uzun, M., & Orhan, A. L. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.03.058
Koronavirüsün Kardiyovasküler Sistem Üzerine Etkileri Işığında Sporcuların Yeniden Sahalara Dönüşünün Değerlendirilmesi
Çayırlı, S., Kartal, A., Yılmaz, O., & Güngör, H. (2021) · Türk Spor Bilimleri Dergisi · doi:10.46385/tsbd.871302
Findings on the relationship between cardiovascular disease and coronavirus disease 2019: a systematic reviewPreprint
da Silva, Y. H., Júnior, J. G. D. M. M., & de Araújo, R. F. F. (2020) · Research Square · doi:10.21203/rs.3.rs-84991/v1
“And nally, QC showed an anti-SARS-CoV-1 effect in vitro, decreasing the glycosylation of ACE2 [43, 44].”
BackgroundInfluential
Potential Adverse Effects of Coronavirus Disease 2019 on the Cardiovascular System
Wang, B.-Y., You, B., & Liu, F. (2021) · Cardiology Plus · doi:10.4103/2470-7511.312592
Beyond the Ventilator - Cardiovascular Management in SARS-CoV-2 Infection
Kloosterboer, A., Vogelsong, M. A., & Brodt, J. L. (2021) · Indian Journal of Respiratory Care · doi:10.4103/ijrc.ijrc_105_20
Role of pulmonary circulation assessment in CT imaging in evaluating the severity and tendency of severe and critical COVID-19 pneumoniaPreprint
Hu, Q., Liu, Y., Pan, Y., Sun, Z., Xiang, M., Li, K., Xia, L., Zhang, H., & Guan, H. (2020) · doi:10.21203/rs.3.rs-32243/v1
“In addition, the main target organ of the COVID-19 infection is the lung, and some recent studies have reported it could also cause myocardial damage [17,20].”
Background
Management of COVID-19 Related Myocarditis: A Systematic Review
Koç, Ş., Şener, Y. Z., Doğan, E., Kırdağ, E. B., Altuntaş, E., Bedir, Ö., & Edem, E. (2021) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v12i5.34533
“In patients with high plasma TnT levels, who were eventually discharged or died, mean duration time of the disease from onset to discharge or death (IQR) was 28 (22-33) and 23.”
Background
Role of human gastrointestinal organoids in discovery and translational medicine
Calor, A. K., van Weissenbruch, M. M., & Senger, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821269-1.00010-2
Cardiovascular complications and covid-19 infection
Pařízek, P. (2021) · Intervenční a akutní kardiologie · doi:10.36290/kar.2021.024
COVID-19 outbreak: The heart in the center?
Chrysohoou, C. A., Oikonomou, E. K., Papanikolaou, A., Xydis, P., & Tsioufis, C. P. (2020) · Journal of Atherosclerosis Prevention and Treatment · doi:10.53590/japt.02.1015
Clinical Determinants and Predictors for Prognosis of SARS-CoV-2 Infected Pediatric Patients in Saudi ArabiaPreprint
Adam, K. M., Elamin, B. K., Alfaifi, J. A., & Abbas, M. M. (2021) · medRxiv · doi:10.1101/2021.07.28.21261284
“severity of COVID-19 is not well defined, the expression of ACE-2 receptors on the pericytes and muscle cells of the heart and overexpression in cases of heart disease [39] as well as the”
Background
COVID-19: Anatomy of a Pandemic
Naji, H. S. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.4.967
“receptors to enter the cell and is responsible for both human to human and cross-species transmission of SARS-CoV-2 [3].”
Background
The state of the circulatory, respiratory and hemostasis organs of the servisemen, suffered from coronavirus pneumonia, in a remote recovery period
Serdyukov, D. Y., Rodichev, N. S., & Tretyakovа, A. A. (2021) · Russian Military Medical Academy Reports · doi:10.17816/rmmar77051
Clinical Manifestations of Cytokine Storm and Immune Response to COVID-19: Literature Review
Kowsarnia, S. (2021) · Open Journal of Internal Medicine · doi:10.4236/ojim.2021.113012
A systematic review of autopsy findings in COVID 19: The road ahead
Faizal, F., Kapoor, U., & Nambiar, B. (2021) · IP Archives of Cytology and Histopathology Research · doi:10.18231/j.achr.2021.036
“COVID-19” and its Cardiovascular Complications – Review
bin Tahir, M. S., ullah, M. S., basit, M., & Rohama, R. (2021) · International Journal of Sciences: Basic and Applied Research
Case Report: Hypercoagulopathy as a Severe Long-term Complication of Post SARS-CoV-19 Infection, Autopsy Findings in Three PatientsPreprint
Zhang, X. R., Agarwal, I., Jing, J., Cheng, L., Scaria, G., Latef, M., & Gattuso, P. (2021) · Research Square · doi:10.21203/rs.3.rs-936635/v1
Soluble ACE2 and Angiotensin II levels Modulated in Hypertensive COVID-19 Patients treated with different Antihypertension Drugs
Yalcin, H. C., Elrayess, M. A., Al-Jighefee, H. T., Al-Ruweidi, M. K. A. A., Almuraikhy, S., & Yassine, H. M. (2021) · Building Resilience at Universities: Role of Innovation and Entrepreneurship · doi:10.29117/quarfe.2021.0085
Peer Review #2 of "WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2 (v0.1)"
(2021) · PeerJ · doi:10.7287/peerj.12262v0.1/reviews/2
Cardiovascular diseases and complication in COVID-19
Pavlović, S. U. (2021) · Medicinski podmladak · doi:10.5937/mp72-33011
COVID-19-Related Cardiac Illness
Hogan, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-85636-6_9
Negative Troponin I as a Predictor of Survival in SARS-Cov-2 (COVID-19)Preprint
Tuarez, F. J. R., Jazaerly, M., Menchaca, K. D., Kothari, V., Cornett, B., & Chait, R. D. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3968917
Pathogenesis of COVID-19 Infection
Radotra, B. D. (2021) · Springer eBooks · doi:10.1007/978-981-16-5105-2_6
Insights Into the Role of Angiotensin-Converting Enzyme 2 in the Onset of Severe Acute Respiratory Syndrome Coronavirus 2 Pathogenesis
Bharadwaj, S., Dwivedi, V. D., Kang, S. G., Kirtipal, N., & Sobti, R. C. (2021) · Springer eBooks · doi:10.1007/978-981-16-5105-2_13
In Depth Review of COVID-19 Effect on CVS
Delvadiya, R., Jagani, B., Gohel, A., Desai, J., & Ram, D. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v71i01.002
Strategy and molecular mechanism study of cold atmospheric plasma applications in oncotherapy, virucide and nanotechnology
Wang, P. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.214016
Covid-19: Viral Pathogenesis and The Host Immune Response
(2021) · Jordan Journal of Biological Sciences · doi:10.54319/jjbs/140506
Comparison of deep vein thrombosis risks in acute respiratory distress syndrome Caused by COVID-19 and Bacterial Pneumonia: A Retrospective Cohort StudyPreprint
Cui, N., Jiang, C., Yang, C., Zhang, L., & Feng, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1250468/v1
Is SARS CoV-2 a new Frankenstein monster virus? (Preprint)Preprint
El‐Magd, M. A. (2020) · doi:10.2196/preprints.21404
Pathogenesis, Clinical Manifestations and Laboratory Findings of the COVID-19
ISI-SENAI-CIMATEC Group (2020) · Journal of Bioengineering, Technologies and Health · doi:10.34178/jbth.v3i1.115
Cardiovascular Manifestations in Echocardiography in Patients Recently Recovered From COVID-19 Infection
Bensaeed, L. A., Elsherbiny, I. A., Shereef, A. S., & Mohamed, M. M. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.212022
Oral and Gut Health Can Play an Important Role in Psychosomatic Illness Associated with Coronavirus Disease 2019 Patients
Huchegowda, R., Sharma, M. K., Anand, N., & Devadiga, D. (2021) · Neuro - Open Journal · doi:10.17140/noj-8-135

Authors: Chen, L., Li, X., Chen, M., Feng, Y., & Xiong, C.
Affiliations: Fudan University (CN)
Renmin University of China (CN)
Corresponding author: Chen, Liang
Xiong, Chenglong
ORCID: Chen, Liang
Li, Xiangjie
Chen, Mingquan
Feng, Yi
Xiong, Chenglong
Venue: Cardiovascular Research
Publisher: Oxford University Press (OUP)
Published: 2020-03-30
Volume: 116
Issue: 6
Pages: 1097-1100
ISSN: 0008-6363 (ISSN-L)
1755-3245
DOI: 10.1093/cvr/cvaa078
PMC: PMC7184507
OpenAlex: W3014027512
Cited by: 1,163
References: 7
Citations by year: 2026: 19 · 2025: 32 · 2024: 64 · 2023: 148 · 2022: 210 · 2021: 332 · 2020: 355
FWCI: 34.28
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations: Cardiovascular Research (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81872673)
National Key Research and Development Program of China (2017YFC1200203)
Fudan University
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords: ACE2, SARS-CoV-2, COVID-19 pandemic, cardiac injury, pericytes, microvascular dysfunction, heart failure, viral receptor expression, myocardial injury
MeSH terms: Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Heart, Heart Diseases, Humans, Peptidyl-Dipeptidase A, Myocardium, Pneumonia, Viral, Receptors, Virus, Gene Expression, Coronavirus Infections, Pericytes, Gene Expression Profiling, Pandemics, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks